# Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer

> **NCT00063986** · PHASE2 · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 110 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **PROCEDURE:** Minimally invasive esophagectomy (MIE)

## Key facts

- **NCT ID:** NCT00063986
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06-24
- **Primary completion:** 2010-12
- **Final completion:** 2012-08
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2023-06-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00063986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00063986, "Esophagectomy in Treating Patients With High-Grade Dysplasia of the Esophagus or Stage I, Stage II, or Stage III Esophageal Cancer". Retrieved via AI Analytics 2026-09-12 from https://api.ai-analytics.org/clinical/NCT00063986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*